AstraZeneca, the Cambridge-based pharmaceutical group, is teaming up with Oxford University to manufacture and distribute a coronavirus vaccine if clinical trials currently under way show it is effective. News of the partnership boosted AstraZeneca’s share price, helping it to become Britain’s most valuable company by market capitalisation. The potential vaccine, aimed at preventing Covid-19 infection, is being developed at Oxford and is being tested on more than 1,100 healthy human volunteers in the first phase of clinical trials at five centres in southern England. Pascal Soriot, AstraZeneca’s chief executive, said the collaboration combined the university’s expertise in vaccinology and his company’s manufacturing and distribution capabilities. “Our hope is that by joining forces we can accelerate the globalisation of a vaccine to combat the virus and protect people from the deadliest pandemic in a generation,” Soriot said. More than 1,000 volunteers aged between 18 and 55 are taking part in trials of the vaccine, called ChAdOx1 nCoV-19, at five test centres. The results of the trials could be available from May. If the vaccine proves successful, late-stage trials could take place in the middle of this year, in a significant acceleration of the usual vaccine testing process. AstraZeneca aims to produce… Read full this story
- Drugmakers report U.S. shortages of flu vaccine, Tamiflu
- Johnson & Johnson Ebola vaccine gets 100 million euro boost
- Peoria's Huntington University for digital media arts grows enrollment
- 19 recent dining scene developments
- 2013 College football countdown | No. 19: USC
- Head of the Mayor’s Office to Combat Domestic Violence to address the problem at a St. Lucia Consulate town hall meeting
- Controversial bird flu research by Chinese scientists called ‘appallingly irresponsible’
- Flu spray fails again, shot urged
- 'Plantibodies' drugs advance as big pharma stands aside
- Meet the Chicago teen who may cure colon cancer
- Student News: Bernards middle-schoolers give back to community
- Millions spent to push opioid laws
- TRANSCRIPT: President Obama's 2014 State of the Union Address
- Corporate moves overseas concern Delaware officials
- UD lands $250M biopharma project
- World’s helium problem may have just gotten solved
- Student news: Forward Progress for New Brunswick student-athletes
- Poaching slows Mexican wolf population recovery
- Student News: North Plainfield students show what they learned
- Makin Waves with Plainfield's J.M. Benjamin & Lamar Mackson
AstraZeneca partners with Oxford University to produce Covid-19 vaccine have 355 words, post on www.theguardian.com at April 30, 2020. This is cached page on The Best Articles. If you want remove this page, please contact us.